Professional Documents
Culture Documents
Anaesthetist
Disclosures
Off-label use of drugs may be discussed
Objectives
Upon completion of this lecture, participants will be able to
Placenta Accreta
Silver RM. Obstet Gynecol 2006;107:1226
Placenta Previa: Risk for Accreta
Overall CD
1°CD
Cesarean Delivery
and VBAC Rates
VBAC
Vs.
Trial of Labor after Cesarean (TOLAC)
Problems with current data
• Most studies compare by actual mode of delivery, not
intended mode of delivery
• Differentiate indicated from ERCD
• Data are for short-term outcomes
• US vs. non-US data
• Gestational age
• Retrospective vs. prospective
• All observational
• Tertiary care settings
AHRQ Publication No. 10-E003
Maternal Death
16
14
12 13.4
Deaths per 100,000
10
2 3.8
0
TOLAC ERCD
95% CI: 0.9-15.5 4.3-41.6
Guise JM. Obstet Gynecol 2010;115:1267
120 133
Deaths per 100,000
100
80
60
40 50
20 TOLAC ERCD
0
Guise JM. Obstet Gynecol 2010;115:1267
Systematic Review: Neonatal Summary
AHRQ Publication No. 10-E003
100
80
60
40 50
20
3.8 13.4
0
Maternal Perinatal
Predicting Risk of Uterine Rupture?
N = 11,855
AUC 0.627
FT < 2.3 mm
AUC 0.88 (95% CI 0.79-0.98)
PloS One 2017;12:e0187850
http://www.bsc.gwu.edu/mfmu/vagbirth.html
Grobman WA. Am J
Perinatol 2009;26:693
Grobman WA. Am J Perinatol 2009;26:693